Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 334 followers
Latest posts
Last updated about 2 hours ago
Human medicines European public assessment report (EPAR): Kesimpta, ofatumumab, Date of authorisation: 26/03/2021, Revision: 16, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Kesimpta, ofatumumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of authorisation: 18/05/2020, Revision: 22, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of...
Human medicines European public assessment report (EPAR): Arexvy, Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted), Date of authorisation: 06/06/2023, Revision: 12, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Arexvy, Respiratory Syncytial Virus (RSV)...
Human medicines European public assessment report (EPAR): Ryeqo, relugolix,estradiol,norethisterone acetate, Date of authorisation: 16/07/2021, Revision: 9, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Ryeqo, relugolix,estradiol,norethisterone acetate, Date of...
Human medicines European public assessment report (EPAR): Samsca, tolvaptan, Date of authorisation: 02/08/2009, Revision: 17, Status: Authorised
about 3 hours ago
Human medicines European public assessment report (EPAR): Samsca, tolvaptan, Date of authorisation...
Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency - Description of the Journal/Reference databases used
about 19 hours ago
Monitoring of medical literature and the entry of relevant information into the...
International Pharmaceutical Abstracts (IPA) journals
about 19 hours ago
International Pharmaceutical Abstracts (IPA) journals
Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Date of authorisation: 15/09/2023, Revision: 6, Status: Authorised
about 20 hours ago
Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Rubraca, rucaparib, Date of authorisation: 23/05/2018, Revision: 19, Status: Authorised
about 20 hours ago
Human medicines European public assessment report (EPAR): Rubraca, rucaparib, Date of authorisation...
Human medicines European public assessment report (EPAR): Vanflyta, quizartinib, Date of authorisation: 06/11/2023, Revision: 5, Status: Authorised
about 20 hours ago
Human medicines European public assessment report (EPAR): Vanflyta, quizartinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Tavneos, avacopan, Date of authorisation: 11/01/2022, Revision: 9, Status: Revoked
about 21 hours ago
Human medicines European public assessment report (EPAR): Tavneos, avacopan, Date of authorisation...